Troubles vésicosphinctériens et syndrome métabolique : étude prospective

Boudokhane, S.; Marmouche, H.; Klii, R.; Jellad, A.; Mahjoub, S.; Frih, Z. Ben Salah

doi:10.1016/j.purol.2012.10.009

Cited by 9 publications

(15 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dysuria in metabolic syndrome is correlated of diabetic neuropathy [14]. About overactive bladder and leak urinary our results are similar to data of literature [5,14]. In our study, dysuria is less frequent [14].…”

Section: Discussionsupporting

confidence: 91%

“…Boudokhane and al have found overactive bladder in 85.2% of patients with metabolic syndrome. There is no gender difference [14]. Others authors have noted that frequency of overactive bladder in metabolic syndrome depends on sex.…”

Section: Discussionmentioning

confidence: 97%

“…Others authors have noted that frequency of overactive bladder in metabolic syndrome depends on sex. It is more frequent in women [5,14]. Tai and al found frequency of overactive bladders to 52% in women population with metabolic syndrome [16].…”

Section: Discussionmentioning

confidence: 99%

“…Leak urinary represented 38.2%. Dysuria is less frequent [14]. Dysuria in metabolic syndrome is correlated of diabetic neuropathy [14].…”

Section: Discussionmentioning

confidence: 99%

“…Urinary disorders in metabolic syndrome are studied. Diabetes, high body circumference, high blood pressure are recognized as risk factors of urinary disorders [10,5,12,13,8,11,14]. Their impact on quality of patients life poorly documented.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Quality of Life and Urinary Disorders in Metabolic Syndrome

Diagne¹,

Khachat²,

Azanmasso³

et al. 2014

AJBLS

View full text Add to dashboard Cite

Introduction: Risk factors of urinary disorders in metabolic syndrome are known. Effect of their association is poorly documented. Objectives: Determine the types of metabolic syndrome as a largest provider of urinary disorders and impact of these on the quality of life. Methodology: We conducted a cross-sectional, descriptive, analytical multicenter study from january to May 2013. It was done in three centers: the departments of Physical Medicine and endocrinology of university hospital Ibn Rochd of Casablanca and the Lions Club's "Insulin bank" of Cotonou, Benin. All patients with metabolic syndrome were included. Metabolic syndrome was diagnosed for NCEP ATP III criteria. Variables such as demographic characteristics, metabolic syndrome, glycemia, triglyceridemia and HDL cholestrolemia were noted. Evaluation of Urinary disorder was conducted by Urinary Symptoms Profile scale (USP). Urinary Symptoms Profile scale has ten items. It accesses urinary incontinence, urge incontinence and dysuria. Evaluation of quality of life was conducted by SF Qualiveen Scale. SF Qualiveen evaluates bother with limitations, fears, feeling and frequency of limitations. Results: we included 68 patients. Women represented 82.2%. The mean of age was 54.43 years. Patients with diabetes represented 98.5%. The main types of metabolic syndrome were the following associations: diabetes, high blood pressure and obesity (19.1%); diabetes, high blood pressure and dyslipidemia (16.2%); diabetes, obesity and dyslipidemia (8.8%). Urinary disorders are reported in 51.5% of cases. The main urinary symptoms were overactive bladder (58.8%), urinary incontinence (32.4%) and dysuria (16.2%). Overactive bladder was found in 64.28% of women and in 50% of men. Forty seven point thirty six percent (47.36%) of patients with diabetic neuropathy have manifested dysuria. The average score of USP was 8+/-8.8. The average score of Qualiveen was 1.25. Metabolic syndrome is significantly associated to urinary disorders, especially the types diabetes-obesity-dyslipidemia (p=0.004) and diabetes-obesity-high blood pressure (HBP) p=0.001). Discussion: Urinary disorders in metabolic syndrome are dominated for overactive bladder. Overactive bladder is more frequent in women and patients aged less than 40 years. Risk factors of urinary disorder are diabetes and obesity. In metabolic syndrome, quality of life is impaired in patients with urinary disorders. Conclusion: Metabolic syndrome, especially the associations diabetes-obesity and diabetes-high body circumference (HBC) to others items, increased risk of urinary disorders. Urinary symptoms in metabolic syndrome are dominated by overactive bladder. Overactive bladder is more frequent in women and patients aged less than 40 years. Dysuria is unusual in metabolic syndrome and it's not always correlated to diabetic neuropathy. Quality of life is impaired in patients with urinary disorder.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 99%

“…Leak urinary represented 38.2%. Dysuria is less frequent [14]. Dysuria in metabolic syndrome is correlated of diabetic neuropathy [14].…”

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Quality of Life and Urinary Disorders in Metabolic Syndrome

Diagne¹,

Khachat²,

Azanmasso³

et al. 2014

AJBLS

View full text Add to dashboard Cite

show abstract

How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI‐RS 2023: Part 1

Finazzi Agrò,

Rosato,

Wagg

et al. 2024

Neurourology and Urodynamics

View full text Add to dashboard Cite

IntroductionOveractive bladder (OAB) and Underactive bladder (UAB) could be associated with metabolic syndrome, affective disorders, sex hormone deficiency, changes in urinary microbiota, functional gastrointestinal disorders, or autonomic nervous system dysfunction.ObjectivesThe aim of this Think Tank was to provide a guide on how to investigate OAB and/or detrusor underactivity (DU) patients to better clarify the underlying pathophysiology and possibly personalize the treatment.MethodsA compendium of discussion based on the current evidence related to phenotyping patients with OAB or DU investigating metabolic, neurogical, psychological and gastrointestinal aspects with the aim to personalize the treatment.Results and ConclusionsThe article emphasizes the critical significance of adopting a comprehensive yet tailored approach to phenotyping patients with lower urinary tract symptoms, such as OAB and UAB. The intricate interplay between the lower urinary tract and various factors, metabolic, neurological, psychological, and gastrointestinal can define unique LUT profiles, enabling personalized therapies to replace the one‐size‐fits‐all approach.

show abstract